4.7 Article Proceedings Paper

beta-catenin, cartilage, and osteoarthritis

Journal

SKELETAL BIOLOGY AND MEDICINE
Volume 1192, Issue -, Pages 344-350

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1749-6632.2009.05212.x

Keywords

conditional activation; beta-catenin; articular chondrocyte; osteoarthritis

Funding

  1. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055915] Funding Source: NIH RePORTER
  2. NIAMS NIH HHS [R01 AR055915-02, R01 AR055915, R01 AR055915-01A2] Funding Source: Medline

Ask authors/readers for more resources

The early cellular events during the development of osteoarthritis (OA) are accelerated articular chondrocyte maturation and extracellular matrix degradation, which are usually seen in the weight-bearing region of articular cartilage. The results of our recent studies from transgenic OA mouse models indicate that upregulation of beta-catenin signaling in articular chondrocytes is most likely responsible for the conversion of normal articular chondrocytes into maturing (arthritic) chondrocytes, which is associated with activation of chondrocyte maturational genes and matrix degradation. Conditional activation of the beta-catenin gene in articular chondrocytes leads to an OA-like phenotype. Overexpression of Smurf2, an E3 ubiquitin ligase, also induces an OA-like phenotype through upregulation of beta-catenin signaling. In addition, beta-catenin upregulation was also found in articular cartilage tissues in patients with OA. These findings indicate that beta-catenin plays a central role in articular cartilage function and that activation of beta-catenin signaling may represent a pathologic mechanism for OA development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available